![Michal Jerzy Walczak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michal Jerzy Walczak
Directeur Général chez
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Fortune : 18 M $ au 31/08/2026
Profil
Michal Jerzy Walczak currently works at Captor Therapeutics SA, as Chief Executive Officer & Chief Scientific Officer from 2025.
Dr. Walczak received his graduate degree from the University of Virginia and doctorate degree from Swiss Federal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAPTOR THERAPEUTICS SA 14,42% | 15/04/2026 | 916 028 ( 14,42% ) | 18 M $ | 31/08/2026 |
Postes actifs de Michal Jerzy Walczak
| Sociétés | Poste | Début |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Directeur Général | 31/05/2025 |
Formation de Michal Jerzy Walczak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
